Musculoskeletal system

被引：24

作者：

Jadvar, H ^{[1
]}

Gamie, S ^{[1
]}

Ramanna, L ^{[1
]}

Conti, PS ^{[1
]}

机构：

[1] Univ So Calif, Keck Sch Med, Dept Radiol, Div Nucl Med, Los Angeles, CA 90033 USA

来源：

SEMINARS IN NUCLEAR MEDICINE | 2004年 / 34卷 / 04期

关键词：

D O I：

10.1053/j.semnuclmed.2004.06.002

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Diagnostic imaging has played a major role in the evaluation of patients with cancers of the bone and soft tissue. The imaging modalities have included radiography, computed tomography, magnetic resonance imaging, and bone scintigraphy. Current experience suggests that functional imaging with positron emission tomography (PET) and [F-18]fluorodeoxyglucose (FDG) may also have an important role in the imaging evaluation of patients with bone and soft tissue sarcoma, including guiding biopsy, detecting local recurrence in amputation stumps, detecting metastatic disease, predicting and monitoring response to therapy, and assessing for prognosis. Prospective studies with large patient groups will be essential to define the exact diagnostic role of FDG PET in this clinical setting, which should also include an evaluation of the cost-effectiveness and the short-term and long-term benefits in clinical decision making and management. In this article, we review the diagnostic utility of dedicated PET and PET combined with computed tomography imaging system in the evaluation of patients with bone and soft tissue malignancies. (C) 2004 Elsevier Inc. All rights reserved.

引用

页码：254 / 261

页数：8

共 74 条

[21] 18FDG PET scanning of benign and malignant musculoskeletal lesions [J].

Feldman, F ;

van Heertum, R ;

Manos, C .

SKELETAL RADIOLOGY, 2003, 32 (04) :201-208

[22]

Folpe AL, 2000, CLIN CANCER RES, V6, P1279

[23] Evaluation of chemotherapy response in primary bone tumors with F-18FDG positron emission tomography compared with histologically assessed tumor necrosis [J].

Franzius, C ;

Sciuk, J ;

Brinkschmidt, C ;

Jürgens, H ;

Schober, O .

CLINICAL NUCLEAR MEDICINE, 2000, 25 (11) :874-881

[24] FDG-PET for detection of osseous metastases from malignant primary bone tumours:: comparison with bone scintigraphy [J].

Franzius, C ;

Sciuk, J ;

Daldrup-Link, HE ;

Jürgens, H ;

Schober, O .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (09) :1305-1311

[25]

Franzius C, 2002, J NUCL MED, V43, P1012

[26] FDG-PET for detection of pulmonary metastases from malignant primary bone tumors:: Comparison with spiral CT [J].

Franzius, C ;

Daldrup-Link, HE ;

Sciuk, J ;

Rummeny, EJ ;

Bielack, S ;

Jürgens, H ;

Schober, O .

ANNALS OF ONCOLOGY, 2001, 12 (04) :479-486

[27] Diagnosis of a cardiac angiosarcoma by fluorine-18 fluordeoxyglucose positron emission tomography [J].

Freudenberg, L. S. ;

Rosenbaum, S. J. ;

Schulte-Herbrueggen, J. ;

Eising, E. G. ;

Lauenstein, T. ;

Wolff, A. ;

Bockisch, A. .

EUROPEAN RADIOLOGY, 2002, 12 (Suppl 3) :S158-S161

[28]

Garcia JR, 1996, J NUCL MED, V37, P1476

[29]

Gayed I, 2004, J NUCL MED, V45, P17

[30] Can FDG PET be used to successfully direct preoperative biopsy of soft tissue tumours? [J].

Hain, SF ;

O'Doherty, MJ ;

Bingham, J ;

Chinyama, C ;

Smith, MA .

NUCLEAR MEDICINE COMMUNICATIONS, 2003, 24 (11) :1139-1143

← 1 2 3 4 5 6 7 8 →